Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PETTER MATHIAS BJORNSTAD

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1023363751
CMS profile
2784377
Location
SEATTLE, WA

General Payments · PY2018–2024

$120,589.28

  • Reported across 135 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$18,725.56

21 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Eli Lilly and Company $5,995.00 6
Bayer HealthCare Pharmaceuticals Inc. $5,603.00 5
Novo Nordisk AS $4,275.00 4
Acerta Pharma LLC $1,611.00 2
Boehringer Ingelheim International GmbH $1,241.56 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,024.65 4
PY2019 $21,511.20 18
PY2020 $17,023.66 9
PY2021 $10,397.09 10
PY2022 $16,717.16 31
PY2023 $35,189.96 42
PY2024 $18,725.56 21

Payment records · PY2024 (21)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $1,074.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 1105875431 CMS
AstraZeneca Pharmaceuticals LP $537.00 10/22/2024 Consulting Fee Undisputed 01/23/2026 1104418215 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,606.50 03/07/2024 Consulting Fee Undisputed 01/23/2026 1086137029 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,606.50 03/07/2024 Consulting Fee Undisputed 01/23/2026 1086224962 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,200.00 06/03/2024 Consulting Fee Undisputed 01/23/2026 1086190972 CMS
Bayer Healthcare Pharmaceuticals Inc. $595.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 1086130562 CMS
Bayer Healthcare Pharmaceuticals Inc. $595.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 1086195502 CMS
Boehringer Ingelheim International GmbH $617.89 12/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117841773 CMS
Boehringer Ingelheim International GmbH $106.56 12/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117841775 CMS
Boehringer Ingelheim International GmbH $238.96 12/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117841777 CMS
Boehringer Ingelheim International GmbH $278.15 12/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117841779 CMS
Eli Lilly and Company $412.50 02/08/2024 Consulting Fee Undisputed 01/23/2026 1135317916 CMS
Eli Lilly and Company $412.50 02/12/2024 Consulting Fee Undisputed 01/23/2026 1135293569 CMS
Eli Lilly and Company $1,320.00 04/10/2024 Consulting Fee Undisputed 01/23/2026 1135317919 CMS
Eli Lilly and Company $412.50 06/11/2024 Consulting Fee Undisputed 01/23/2026 1135317923 CMS
Eli Lilly and Company $2,750.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1135324006 CMS
Eli Lilly and Company $687.50 10/17/2024 Consulting Fee Undisputed 01/23/2026 1135278635 CMS
Novo Nordisk AS $830.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 1096552445 CMS
Novo Nordisk AS $2,075.00 03/31/2024 Consulting Fee Undisputed 01/23/2026 1096552393 CMS
Novo Nordisk AS $125.00 10/21/2024 Food and Beverage Undisputed 01/23/2026 1096552695 CMS
Novo Nordisk AS $1,245.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 1096553233 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.